© Copyright 2025 American Medical Association. All rights reserved.
Laparoscopy, surgical, ablation of uterine fibroid(s) is a minimally invasive procedure aimed at treating benign tumors known as uterine fibroids, which develop from the muscle tissue of the uterus (myometrium). These fibroids can vary in location and type: submucous fibroids extend into the uterine cavity, intramural fibroids are embedded within the uterine wall, and subserous fibroids are located on the outer surface of the uterus. The procedure utilizes radiofrequency ablation (RFA) technology, which is effective for fibroids of various sizes and locations. During the procedure, two small incisions are made—one in the infraumbilical region and another in the suprapubic region—to facilitate the insertion of laparoscopic instruments. Pneumoperitoneum, or the introduction of gas into the abdominal cavity, is established to create a working space for the surgeon. A thorough laparoscopic examination is conducted, often accompanied by intraoperative ultrasound, to accurately identify all fibroid tumors present. The RFA device is then introduced into the peritoneal cavity through a small incision, allowing for precise targeting of the fibroid. The procedure involves advancing the RFA tip into the fibroid, deploying an electrode array, and using laparoscopic visualization along with ultrasound guidance to ensure correct placement. Once the electrode array is activated, it heats to a predetermined target temperature, which is maintained for a specified duration to achieve complete ablation of the fibroid. After treating all identified fibroids, the RFA device is removed, the CO2 gas is evacuated from the peritoneal cavity, and the skin incisions are closed, resulting in minimal recovery time and reduced postoperative discomfort for the patient.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure is indicated for the treatment of uterine fibroids, which may present with various symptoms or conditions. The following are explicitly provided indications for performing laparoscopic surgical ablation of uterine fibroids:
The laparoscopic surgical ablation of uterine fibroids involves several key procedural steps, each critical for the successful treatment of the fibroids:
Post-procedure care involves monitoring the patient for any immediate complications and ensuring a smooth recovery. Patients can typically expect a shorter recovery time due to the minimally invasive nature of the procedure. Instructions for post-operative care may include managing pain with prescribed medications, monitoring for any signs of infection at the incision sites, and following up with the healthcare provider to assess the success of the procedure and any further treatment needs. Patients are generally advised to avoid strenuous activities for a specified period to facilitate healing.
| Short Descr | LAPS ABLTJ UTERINE FIBROIDS | Medium Descr | LAPS ABLTJ UTERINE FIBROIDS W/INTRAOP US GDN | Long Descr | Laparoscopy, surgical, ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring, radiofrequency | Status Code | Active Code | Global Days | 090 - Major Surgery | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 2 - Payment restriction for assistants at surgery does not apply to this procedure... | Co-Surgeons (62) | 2 - Co-surgeons permitted and no documentation required if the two- specialty requirement is met. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | ASC Payment Indicator | Non office-based surgical procedure added in CY 2008 or later; payment based on OPPS relative payment weight. | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | P5E - Ambulatory procedures - other | MUE | 1 |
| 51 | Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d). | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 80 | Assistant surgeon: surgical assistant services may be identified by adding modifier 80 to the usual procedure number(s). | GC | This service has been performed in part by a resident under the direction of a teaching physician | SG | Ambulatory surgical center (asc) facility service | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Changed | Guideline information changed. |
| 2017-01-01 | Added | Added |
| 2017-01-01 | Changed | Revise Placement: Delete it from subsection Oviduct/Ovary and move it to Corpus Uteri subsection. Change per CPT errata dated 2017-08-02. |
Get instant expert-level medical coding assistance.